NYSE: RJACJackson Acquisition Co Stock
$10.39+0.00 (+0%)
Updated Jun 6, 2023
RJAC Price
$10.39
Fair Value Price
N/A
Market Cap
$288.97M
52 Week Low
$9.79
52 Week High
$10.72
P/E
39.96x
P/B
-36.78x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$7.28M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.24
Operating Cash Flow
-$1M
Beta
-0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
RJAC Overview
Jackson Acquisition Company is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It itargets the healthcare services and healthcare tech sectors. Jackson Acquisition was founded in 2021 and is headquartered in Alpharetta, GA.
Zen Score
–
Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RJAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RJAC was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RJAC is good value based on its earnings relative to its share price (39.96x), compared to the US market average (53.54x)
P/E vs Market Valuation
RJAC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more RJAC due diligence checks available for Premium users.
Be the first to know about important RJAC news, forecast changes, insider trades & much more!
RJAC News
Valuation
RJAC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
39.96x
Industry
41.98x
Market
53.54x
RJAC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RJAC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
RJAC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-36.78x
Industry
-27.46x
RJAC's financial health
Profit margin
Revenue
$0.0
Net Income
$1.5M
Profit Margin
0%
RJAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$231.4M
Liabilities
$9.8M
Debt to equity
-1.24
RJAC's short-term liabilities ($1.58M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RJAC's long-term liabilities ($8.19M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RJAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RJAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$538.6k
Investing
$367.7k
Financing
$0.0
RJAC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
RJAC vs Shell Company Stocks
Jackson Acquisition Co Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.